David Smoller
Founder presso Canopy Biosciences LLC
Profilo
Dr. David A.
Smoller served as CEO of Sage Labs, a Life Science CRO based on Gene Editing technology until acquired By Horizon Discovery ( HZD.L).
David continued at Horizon as Chief Business Officer and Board Member until December of 2015.
Previous to those roles, Dr. Smoller was the Chief Scientific Officer of Sigma-Aldrich Corporation from February 2011 until August 3, 2012.
Dr. Smoller served as the President of Research Biotech Business Unit of Sigma-Aldrich Corp.
since July 5, 2007 and served as its Vice President of Research and Development since June 1, 2004.
Dr. Smoller served as President and Chief Executive Officer of ProteoPlex, a seed stage spinout focusing on functional genomics.
Dr. Smoller founded ProteoPlex in 2001 and led the St. Louis-based company through its product development and final acquisition by Merck KgA.
In 1992, Dr. Smoller founded Genome Systems Inc., in St. Louis, which provided the scientific community with access to genome project-related technologies.
Dr. Smoller stayed at the helm of Genome Systems, Inc. until it was acquired in 1996 by the Incyte Corporation, based in Palo Alto, California.
Dr. Smoller joined Incyte as Vice President eventually becoming Senior Vice President, overseeing the Global Genomics, Business Unit.
During his tenure at Incyte he grew the St. Louis staff to more than 250 people.
Dr. Smoller earned a doctorate degree in Molecular Biology and a bachelor’s degree in Biology from Emory University in Atlanta, Georgia.
He completed a postdoctoral fellowship from Washington University in the Drosophila Genome project and a postdoctoral fellowship at Monsanto Corporation.
Posizioni attive di David Smoller
| Società | Posizione | Inizio |
|---|---|---|
Kypha, Inc.
 Kypha, Inc. Medical/Nursing ServicesHealth Services Kypha, Inc. engages in the development of devices and products to monitor and treat inflammatory and autoimmune disorders. Its products include Comp act, RapiPlex, and sample stabilization. The company was founded by Paul K. Olson and Chad M. Stiening on January 14, 2011 and is headquartered in St. Louis, MO. | Director/Board Member | - |
Immunophotonics, Inc.
 Immunophotonics, Inc. Pharmaceuticals: MajorHealth Technology Immunophotonics, Inc. develops proprietary novel drug product for use in a minimally invasive therapeutic cancer vaccine. Its vaccine process under development, inCVAX, is a two injection procedure into one or more selected tumors: The first injection is a needle with an optical fiber (coupled to a laser) that heats selected tumor(s) locally; The second injection is experimental drug product, a proprietary synthesized carbohydrate polymer, that is intended to recruit and activate antigen-presenting cells, potentially triggering a cascade that leads to a systemic anti-tumor immune response. The company was founded by Lu Alleruzzo and Tomas Hode in 2009 and is headquartered in St. Louis, MI. | Director/Board Member | - |
Canopy Biosciences LLC
 Canopy Biosciences LLC Electronic Equipment/InstrumentsElectronic Technology Canopy Biosciences LLC engages in the provision of products and services for gene editing, gene expression analysis and regulation, and bioprocessing. It offers crispr complete kits, mirna crispr knockout kits, clia certified services, compbio, mirna mimics, and cho complete. The company was founded by David Adam Smoller, Edward J. Weinstein and Crystal Winkeler in 2016 and is headquartered in St. Louis, MO. | Founder | 01/01/2016 |
Cultivation Capital LLC
 Cultivation Capital LLC Investment ManagersFinance Cultivation Capital LLC (Cultivation Capital) is a venture capital firm founded in 2012 by Brian Matthews, Cliff Holekamp, Jim McKelvey, Kyle Welborn, and Peter Esparrago. The firm is headquartered in St. Louis, Missouri. | Private Equity Investor | 01/09/2012 |
Thompson Street Capital Managers LLC
 Thompson Street Capital Managers LLC Investment ManagersFinance Thompson Street Capital Managers LLC (Thompson Street Capital) is a private equity subsidiary of Thompson Street Capital Partners LLC, founded in 2000 by James A. Cooper and Peter Finley. The firm is headquartered in St. Louis, Missouri. | Consultant / Advisor | - |
BioGenerator (Venture Capital)
 BioGenerator (Venture Capital) Investment ManagersFinance BioGenerator (Venture Capital) (BioGenerator) is a venture capital subsidiary of BioGenerator founded in 2003. The firm is headquartered in St. Louis, Missouri. | Private Equity Investor | - |
Solis Agrosciences, Inc.
 Solis Agrosciences, Inc. Information Technology ServicesTechnology Services Solis Agrosciences, Inc. is a plant sciences company located in the 39N Innovation District. The American company offers technology and research services to agricultural innovators with the goal of designing and delivering new biotech plant traits in multiple crops using their proprietary Plant Pipeline as a Service (PPaaS™) for gene-edited and transgenic plant generation and characterization. Solis has a team of experienced scientists, entrepreneurs, and agtech leaders to support research needs and accelerate agricultural innovation to solve food and climate challenges. The company was founded by Charlie W. Bolten and the CEO is Tom Cohen. | Director/Board Member | - |
Vector Laboratories, Inc.
 Vector Laboratories, Inc. Chemicals: Major DiversifiedProcess Industries Vector Laboratories, Inc. develops, manufactures and markets labeling and detection reagents for immunohistochemistry, immunofluorescence, DNA/RNA and glycobiology. Its products include neuronal tracers, ultrapure immunological products, and novel reagents for detection and isolation of nucleic acids, fusion proteins and carbohydrates. The company was founded in 1976 and is headquartered in Burlingame, CA. | Director/Board Member | 01/09/2021 |
Precedenti posizioni note di David Smoller
| Società | Posizione | Fine |
|---|---|---|
| HORIZON DISCOVERY GROUP PLC | Director/Board Member | 12/11/2015 |
| ░░░░ ░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formazione di David Smoller
| Washington University in St. Louis | Graduate Degree |
| Emory University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| MERCK KGAA | Health Technology |
| SBI HOLDINGS, INC. | Finance |
| Aziende private | 17 |
|---|---|
Sigma-Aldrich Corp.
 Sigma-Aldrich Corp. Wholesale DistributorsDistribution Services Sigma-Aldrich Corp. operates as a life science and technology material company. It develops, manufactures, purchases and distributes a broad range of biochemical and organic chemicals. Its services include basic research, product and process development, manufacturing and production, regulatory compliance, and facility operations. was founded in May 1975 and is headquartered in St. Louis, MO. | Distribution Services |
Immunophotonics, Inc.
Immunophotonics, Inc. Pharmaceuticals: MajorHealth Technology Immunophotonics, Inc. develops proprietary novel drug product for use in a minimally invasive therapeutic cancer vaccine. Its vaccine process under development, inCVAX, is a two injection procedure into one or more selected tumors: The first injection is a needle with an optical fiber (coupled to a laser) that heats selected tumor(s) locally; The second injection is experimental drug product, a proprietary synthesized carbohydrate polymer, that is intended to recruit and activate antigen-presenting cells, potentially triggering a cascade that leads to a systemic anti-tumor immune response. The company was founded by Lu Alleruzzo and Tomas Hode in 2009 and is headquartered in St. Louis, MI. | Health Technology |
Kypha, Inc.
Kypha, Inc. Medical/Nursing ServicesHealth Services Kypha, Inc. engages in the development of devices and products to monitor and treat inflammatory and autoimmune disorders. Its products include Comp act, RapiPlex, and sample stabilization. The company was founded by Paul K. Olson and Chad M. Stiening on January 14, 2011 and is headquartered in St. Louis, MO. | Health Services |
Apse, Inc.
 Apse, Inc. Agricultural Commodities/MillingProcess Industries Apse, Inc. offers technology and strategy services. It develops technology that will allow the cost efficient production of RNA for broad acre topical RNAi uses in agriculture. The company was founded by Juan Arhancet in 2011 and is headquartered in St. Louis, MO. | Process Industries |
Genome Systems, Inc.
 Genome Systems, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Incyte Corp., Genome Systems, Inc. is a private company that researches and develops biotechnical products. The company is based in St. Louis, MO. The company was founded by David Adam Smoller. Genome Systems was acquired by Incyte Corp. on July 23, 1996 for $7.33 million. | Commercial Services |
ProteoPlex, Inc.
 ProteoPlex, Inc. Miscellaneous Commercial ServicesCommercial Services ProteoPlex, Inc. provides research and development services for the pharmaceutical industry. The company was founded by Samuel T. LaBrie and is headquartered in St. Louis, MO. | Commercial Services |
Thompson Street Capital Managers LLC
Thompson Street Capital Managers LLC Investment ManagersFinance Thompson Street Capital Managers LLC (Thompson Street Capital) is a private equity subsidiary of Thompson Street Capital Partners LLC, founded in 2000 by James A. Cooper and Peter Finley. The firm is headquartered in St. Louis, Missouri. | Finance |
BioGenerator (Venture Capital)
BioGenerator (Venture Capital) Investment ManagersFinance BioGenerator (Venture Capital) (BioGenerator) is a venture capital subsidiary of BioGenerator founded in 2003. The firm is headquartered in St. Louis, Missouri. | Finance |
| EMG Biosciences | |
Adarza BioSystems, Inc.
 Adarza BioSystems, Inc. Electronic Equipment/InstrumentsElectronic Technology Adarza BioSystems, Inc. develops and manufacturers a multiplex immunoassay technology that can identify proteins and genetic markers in medical specimens. The firm operates as a medical diagnostics company which also develops a rapid and label-free biological assay platform for measuring clinical and point-of-care samples and also its technology allows hundreds of tests to be run simultaneously on a single chip. The company was founded by Benjamin L. Miller, Randolph R. Henke, Terry Gronwall and Christopher C. Striemer in 2008 and is headquartered in St. Louis, MO. | Electronic Technology |
Vector Laboratories, Inc.
Vector Laboratories, Inc. Chemicals: Major DiversifiedProcess Industries Vector Laboratories, Inc. develops, manufactures and markets labeling and detection reagents for immunohistochemistry, immunofluorescence, DNA/RNA and glycobiology. Its products include neuronal tracers, ultrapure immunological products, and novel reagents for detection and isolation of nucleic acids, fusion proteins and carbohydrates. The company was founded in 1976 and is headquartered in Burlingame, CA. | Process Industries |
Sigma-Aldrich Co. LLC (Missouri)
 Sigma-Aldrich Co. LLC (Missouri) Miscellaneous Commercial ServicesCommercial Services Sigma-Aldrich Co. is a privately held life science and technology company. They produce chemical and biochemical products and kits for scientific research. The company was founded in 1934 and is headquartered in Saint Louis, MO | Commercial Services |
Cultivation Capital LLC
Cultivation Capital LLC Investment ManagersFinance Cultivation Capital LLC (Cultivation Capital) is a venture capital firm founded in 2012 by Brian Matthews, Cliff Holekamp, Jim McKelvey, Kyle Welborn, and Peter Esparrago. The firm is headquartered in St. Louis, Missouri. | Finance |
Horizon Discovery Group Ltd.
 Horizon Discovery Group Ltd. Medical SpecialtiesHealth Technology Horizon Discovery Group Ltd. is a cell engineering company, which engages in the design and engineering of genetically-modified cells. The firm operates through the following business segments: Products, Services, and Leveraged Research & Development. The Products segment sells cell lines and other products. The Services segment offers cell line manufacturing services. The Leveraged Research & Development segment business unit is operated on a portfolio basis. It serves pharmaceutical, biotechnology, and diagnostic companies. The company was founded by Christopher John Torrance, Adam John Collier, and Alberto Bardelli in July 2005 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Sage Labs, Inc.
 Sage Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Revvity, Inc., Sage Labs, Inc. is a private company that provides animal research models and support services. The company is based in St. Louis, MO. Sage Labs was acquired by Horizon Discovery Group Ltd., part of Revvity, Inc. from December 24, 2020 on September 29, 2014 for $48.05 million. | Commercial Services |
Canopy Biosciences LLC
Canopy Biosciences LLC Electronic Equipment/InstrumentsElectronic Technology Canopy Biosciences LLC engages in the provision of products and services for gene editing, gene expression analysis and regulation, and bioprocessing. It offers crispr complete kits, mirna crispr knockout kits, clia certified services, compbio, mirna mimics, and cho complete. The company was founded by David Adam Smoller, Edward J. Weinstein and Crystal Winkeler in 2016 and is headquartered in St. Louis, MO. | Electronic Technology |
Solis Agrosciences, Inc.
Solis Agrosciences, Inc. Information Technology ServicesTechnology Services Solis Agrosciences, Inc. is a plant sciences company located in the 39N Innovation District. The American company offers technology and research services to agricultural innovators with the goal of designing and delivering new biotech plant traits in multiple crops using their proprietary Plant Pipeline as a Service (PPaaS™) for gene-edited and transgenic plant generation and characterization. Solis has a team of experienced scientists, entrepreneurs, and agtech leaders to support research needs and accelerate agricultural innovation to solve food and climate challenges. The company was founded by Charlie W. Bolten and the CEO is Tom Cohen. | Technology Services |
- Borsa valori
- Insiders
- David Smoller
